138
Views
5
CrossRef citations to date
0
Altmetric
CLINICAL TRIAL REPORT

Effects of Esketamine Combined with Ultrasound-Guided Pectoral Nerve Block Type II on the Quality of Early Postoperative Recovery in Patients Undergoing a Modified Radical Mastectomy for Breast Cancer: A Randomized Controlled Trial

, , , , , & ORCID Icon show all
Pages 3157-3169 | Received 28 Jun 2022, Accepted 29 Sep 2022, Published online: 11 Oct 2022

References

  • Siegel RL, Miller KD, Jemal A. Miller KD and Jemal A: cancer statistics. CA Cancer J Clin. 2016;66:7–30. doi:10.3322/caac.21332
  • So WKW, Marsh G, Ling WM, et al. Anxiety, depression and quality of life among Chinese breast cancer patients during adjuvant therapy. Eur J Oncol Nurs. 2010;14(1):17–22. doi:10.1016/j.ejon.2009.07.005
  • Li T, Mello-Thoms C, Brennan PC. Descriptive epidemiology of breast cancer in China: incidence, mortality, survival and prevalence. Breast Cancer Res Treat. 2016;159(3):395–406. doi:10.1007/s10549-016-3947-0
  • Andersen KG, Aasvang EK, Kroman N, et al. Intercostobrachial nerve handling and pain after axillary lymph node dissection for breast cancer. Acta Anaesthesiol Scand. 2014;58(10):1240–1248. doi:10.1111/aas.12393
  • Bužgová R, Jarošová D, Hajnová E. Assessing anxiety and depression with respect to the quality of life in cancer inpatients receiving palliative care. Eur J Oncol Nurs. 2015;19(6):667–672. doi:10.1016/j.ejon.2015.04.006
  • Breitbart W, Rosenfeld B, Passin H, et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with Cancer. JAMA. 2000;284(22):2907–2911. doi:10.1001/jama.284.22.2907
  • Massie MJ, Gagnon P, Holland JC. Depression and suicide in patients with cancer. J Pain Symptom Manag. 1994;9(5):325–340. doi:10.1016/0885-3924(94)90192-9
  • Chan CM, Wan Ahmad WA, Yusof M, Ho GF, Krupat E. Effects of depression and anxiety on mortality in a mixed cancer group: a longitudinal approach using standardised diagnostic interviews. Psycho-Oncology. 2014;24(6):718–725. doi:10.1002/pon.3714
  • Chia PA, Cannesson M, Bui CCM. Opioid free anesthesia: feasible? Curr Opin Anaesthesiol. 2020;33(4):512–517. doi:10.1097/ACO.0000000000000878
  • Fancellu A, Perra T, Ninniri C, et al. The emerging role of pectoral nerve block (PECS block) in breast surgery: a case-matched analysis. Breast. 2020;26(9):1784–1787. doi:10.1111/tbj.13939
  • Hamp T, Baron-Stefaniak J, Krammel M, et al. Effect of intravenous S-ketamine on the MAC of sevoflurane: a randomised, placebo-controlled, double-blinded clinical trial. Br J Anaesth. 2018;121:1242–1248. doi:10.1016/j.bja.2018.08.023
  • Canuso CM, Singh JB, Fedgchin M, et al. Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study. Focus. 2019;17(1):55–56. doi:10.1176/appi.focus.17105
  • Falk E, Schlieper D, van Caster P, et al. A rapid positive influence of S-ketamine on the anxiety of patients in palliative care: a retrospective pilot study. BMC Palliat Care. 2020;19(1):1. doi:10.1186/s12904-019-0499-1
  • Schwemmer U. Breast surgery and peripheral blocks. Is It Worth It?. Curr Opin Anaesthesiol. 2020;33(3):311–315.
  • Cui X, Zhu C, Chen P, et al. Effect of pectoral nerve block type II under general anesthesia on the immune function of patients with breast cancer. Am J Surg. 2020;220(4):938–944. doi:10.1016/j.amjsurg.2020.03.008
  • Blanco R, Fajardo M, Parras Maldonado T. Ultrasound description of Pecs II (modified Pecs I): a novel approach to breast surgery. Rev Esp Anestesiol Reanim. 2012;59(9):470–475.
  • Myles PS, Weitkamp B, Jones K, et al. Validity and reliability of a postoperative quality of recovery score: the QoR-40. Br J Anaesth. 2000;84(1):11–15. doi:10.1093/oxfordjournals.bja.a013366
  • Bagchi D, Mandal MC, Das S, et al. Bispectral index score and observer’s assessment of awareness/sedation score may manifest divergence during onset of sedation: study with midazolam and propofol. Indian J Anaesth. 2013;57(4):351–357. doi:10.4103/0019-5049.118557
  • Thong ISK, Jensen MP, Miró J, et al. The validity of pain intensity measures: what do the NRS, VAS, VRS, and FPS-R measure? Scand J Pain. 2018;V18N1:99–107. doi:10.1515/sjpain-2018-0012
  • Cassiani-Miranda CA, Scoppetta O, Cabanzo-Arenas DF. Validity of the hospital anxiety and depression scale (Hads) in primary care patients in Colombia. Gen Hosp Psychiatry. 2022;V74N:102–109. doi:10.1016/j.genhosppsych.2021.01.014
  • Turkmen A, Altan A, Turgut N, et al. The correlation between the Richmond agitation-sedation scale and bispectral index during dexmedetomidine sedation. Eur J Anaesthesiol. 2006;V23N4:300–304. doi:10.1017/S0265021506000081
  • Senapathi TGA, Widnyana IMG, Aribawa IGNM, et al. Combined ultrasound- guided Pecs II block and general anesthesia are effective for reducing pain from modified radical mastectomy. J Pain Res. 2019;12:1353–1358. doi:10.2147/JPR.S197669
  • Argiriadou H, Papagiannopoulou P, Foroulis CN, et al. Intraoperative infusion of S(+)-ketamine enhances post-thoracotomy pain control compared with perioperative parecoxib when used in conjunction with thoracic paravertebral ropivacaine infusion. J Cardiothorac Vasc Anesth. 2011;25:455–461. doi:10.1053/j.jvca.2010.07.011
  • Kim JG, Lee HB, Jeon SB. Combination of Dexmedetomidine and Ketamine for Magnetic Resonance Imaging Sedation. Front Neurol. 2019;10:416. doi:10.3389/fneur.2019.00416
  • Chu Q, Zhu K, Bai Y, et al. A single low dose of dexmedetomidine efficiently attenuates esketamine-induced overactive behaviors and neuronal hyperactivities in mice. Front Hum Neurosci. 2021;15:735569. doi:10.3389/fnhum.2021.735569
  • Ewertz M, Jensen AB. Late effects of breast cancer treatment and potentials for rehabilitation. Acta Oncol. 2011;50(2):187–193. doi:10.3109/0284186X.2010.533190
  • Bozymski KM, Crouse EL, Titus-Lay EN, et al. Esketamine: a novel option for treatment-resistant depression. Ann Pharmacother. 2020;54(6):567–576. doi:10.1177/1060028019892644
  • Glue P, Medlicott NJ, Harland S, et al. Ketamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders. J Psychopharmacol. 2017;31(10):1302–1305. doi:10.1177/0269881117705089
  • Zarate CA, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006;63(8):856–864. doi:10.1001/archpsyc.63.8.856
  • Duman RS, Li N, Liu R-J, et al. Signaling pathways underlying the rapid antidepressant actions of ketamine. Neuropharmacology. 2012;62(1):35–41. doi:10.1016/j.neuropharm.2011.08.044
  • Carpi A, Nicolini A, Antonelli A, et al. Cytokines in the management of high risk or advanced breast cancer: an update and expectation. Curr Cancer Drug Targets. 2009;V9N8:888–903. doi:10.2174/156800909790192392
  • Venetsanakos E, Beckman I, Bradley J, et al. High incidence of interleukin 10 mRNA but not interleukin 2 mRNA detected in human breast tumours. r J Cancer. 1997;V75N12:1826–1830.
  • Deegan CA, Murray D, Doran P, et al. Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery. Reg Anesth Pain Med. 2010;V35N6:490–495. doi:10.1097/AAP.0b013e3181ef4d05
  • Helmy SA, Wahby MA, El-Nawaway M. The effect of anesthesia and surgery on plasma cytokine production. Anaesthesia. 1999;54(8):733–738. doi:10.1046/j.1365-2044.1999.00947.x
  • Al-Hashimi M, Scott S, Thompson JP, Lambert D. Opioids and immune modulation: more questions than answers. Br J Anaesth. 2013;111(1):80–88. doi:10.1093/bja/aet153
  • Welters ID, Feurer MK, Preiss V, et al. Continuous S-(+)-ketamine administration during elective coronary artery bypass graft surgery attenuates pro-inflammatory cytokine response during and after cardiopulmonary bypass. Br J Anaesth. 2011;106(2):172–179. doi:10.1093/bja/aeq341
  • Bravo-Cuéllar A, Romero-Ramos JE, Hernández-Flores G, et al. Comparison of two types of anesthesia on plasma levels of inflammatory markers. Cir Cir. 2007;V75N2:99–105.